These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 14504045)
1. The antineoplastic role of bisphosphonates: from basic research to clinical evidence. Santini D; Vespasiani Gentilucci U; Vincenzi B; Picardi A; Vasaturo F; La Cesa A; Onori N; Scarpa S; Tonini G Ann Oncol; 2003 Oct; 14(10):1468-76. PubMed ID: 14504045 [TBL] [Abstract][Full Text] [Related]
2. Inhibitory effects of bisphosphonates on the proliferation of human ovarian cancer cell lines and the mechanism. Hirata J; Kikuchi Y; Kudoh K; Kita T; Seto H Med Chem; 2006 May; 2(3):223-6. PubMed ID: 16948467 [TBL] [Abstract][Full Text] [Related]
3. Mechanisms of action of bisphosphonates on tumor cells and prospects for use in the treatment of malignant osteolysis. Clézardin P; Gligorov J; Delmas P Joint Bone Spine; 2000 Jan; 67(1):22-9. PubMed ID: 10773965 [TBL] [Abstract][Full Text] [Related]
4. Bisphosphonates for cancer treatment: Mechanisms of action and lessons from clinical trials. Van Acker HH; Anguille S; Willemen Y; Smits EL; Van Tendeloo VF Pharmacol Ther; 2016 Feb; 158():24-40. PubMed ID: 26617219 [TBL] [Abstract][Full Text] [Related]
5. [Action of bisphosphonates on malignant osteolysis]. Alexandre C Presse Med; 1999 Sep; 28(28):1536-40. PubMed ID: 10526564 [TBL] [Abstract][Full Text] [Related]
7. Antitumor effects of bisphosphonates. Green JR Cancer; 2003 Feb; 97(3 Suppl):840-7. PubMed ID: 12548584 [TBL] [Abstract][Full Text] [Related]
8. Bisphosphonates: from the laboratory to the clinic and back again. Russell RG; Rogers MJ Bone; 1999 Jul; 25(1):97-106. PubMed ID: 10423031 [TBL] [Abstract][Full Text] [Related]
9. Bisphosphonates in cancer therapy. Stresing V; Daubiné F; Benzaid I; Mönkkönen H; Clézardin P Cancer Lett; 2007 Nov; 257(1):16-35. PubMed ID: 17697748 [TBL] [Abstract][Full Text] [Related]
10. The potential role of bisphosphonates in prostate cancer. Oades GM; Coxon J; Colston KW Prostate Cancer Prostatic Dis; 2002; 5(4):264-72. PubMed ID: 12627210 [TBL] [Abstract][Full Text] [Related]
11. Bisphosphonates: preclinical review. Green JR Oncologist; 2004; 9 Suppl 4():3-13. PubMed ID: 15459425 [TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo antiresorptive effects of bisphosphonates in metastatic bone disease. Kanakis I; Kousidou OCh; Karamanos NK In Vivo; 2005; 19(1):311-8. PubMed ID: 15796191 [TBL] [Abstract][Full Text] [Related]
17. Potential anticancer properties of bisphosphonates: insights from preclinical studies. Clezardin P Anticancer Agents Med Chem; 2012 Feb; 12(2):102-13. PubMed ID: 21864232 [TBL] [Abstract][Full Text] [Related]
18. Bisphosphonates and Cancer: A Relationship Beyond the Antiresorptive Effects. Teixeira S; Branco L; Fernandes MH; Costa-Rodrigues J Mini Rev Med Chem; 2019; 19(12):988-998. PubMed ID: 31020940 [TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo antitumor effects of bisphosphonates. Clézardin P; Fournier P; Boissier S; Peyruchaud O Curr Med Chem; 2003 Jan; 10(2):173-80. PubMed ID: 12570716 [TBL] [Abstract][Full Text] [Related]
20. Bisphosphonates in the treatment of malignant bone disease. Berenson JR; Lipton A Annu Rev Med; 1999; 50():237-48. PubMed ID: 10073275 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]